Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-mobile degranulation and ensuing anaphylactoid response. Codeine suppositories may also be marketed in some countries. In Eire, new polices arrived into impact on one August 2010[90] concerning codeine, on account https://www.codeingil.com/